Literature DB >> 2061855

Angular cheilitis in a group of Sri Lankan adults: a clinical and microbiologic study.

K A Warnakulasuriya1, L P Samaranayake, J S Peiris.   

Abstract

The relative importance of various factors in the pathogenesis of angular cheilitis in a population of Sri Lankan adults was studied. Forty-nine patients with cheilitis were examined clinically and microbiologically. Only 5 of 49 patients were full denture wearers. The clinical presentation of the lesions could be categorized as mild (Type I), moderate (Type II) or severe (Type III) and the duration of the lesions ranged from 1 month to more than 4 yr. Hematologic investigations revealed 18 patients with low hemoglobin 8 of whom had hypochromic, microcytic anaemia. Pathogenic organisms were isolated from 59% of the lesions; Candida spp. in 24 patients and Staph. aureus in 11 patients. A significant positive relationship between commissural leukoplakia and an infective etiology of angles was noted. This study confirms the multifactorial etiology of angular cheilitis while highlighting the varied clinical presentation of the lesions in an Asian population.

Entities:  

Mesh:

Year:  1991        PMID: 2061855     DOI: 10.1111/j.1600-0714.1991.tb00915.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  3 in total

1.  Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review.

Authors:  Kausar Sadia Fakhruddin; Lakshman Perera Samaranayake; Borvornwut Buranawat; Hien Ngo
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

2.  Comparative study on the microbiological features of angular cheilitis in HIV seropositive and HIV seronegative patients from South India.

Authors:  P Anitha Krishnan; Ranganathan Kannan
Journal:  J Oral Maxillofac Pathol       Date:  2013-09

3.  Prevalence of lip lesions in an Indian population.

Authors:  Santosh Patil; Sneha Maheshwari
Journal:  J Clin Exp Dent       Date:  2014-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.